Hhlr Advisors, Ltd. Dyne Therapeutics, Inc. Transaction History

Hhlr Advisors, Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$10.88 - $15.0 $5.02 Million - $6.92 Million	-461,247 Reduced 49.09%	478,401 $5.51 Million
Q4 2022 Feb 14, 2023	SELL	$9.37 - $13.8 $565,498 - $832,857	-60,352 Reduced 6.04%	939,648 $10.9 Million
Q1 2021 May 17, 2021	BUY	$14.0 - $29.3 $5.6 Million - $11.7 Million	400,000 Added 66.67%	1,000,000 $15.5 Million
Q3 2020 Nov 16, 2020	BUY	$20.0 - $23.9 $12 Million - $14.3 Million	600,000 New	600,000 $12.1 Million

210

102M

234K

238K

Ticker DYN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,765,400
Market Cap $1.55B
Description
Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...

Get notified when there are updates to the investment portfolio of Hhlr Advisors, Ltd., based on Form 13F filings with the SEC.

Stay updated on Hhlr Advisors, Ltd. with notifications on news.